The Clinical Characteristics of New-Onset Epilepsy in the Elderly and Risk Factors for Treatment Outcomes of Antiseizure Medications

Overview

Journal Front Neurol

Specialty Neurology

Date 2022 Mar 11

PMID 35273558

Authors

Jing Qi

Xiao Liu

Na Xu

Qun Wang

Affiliations

Soon will be listed here.

Abstract

Objective: To describe the clinical characteristics of elderly patients with new-onset epilepsy in a Class A tertiary comprehensive hospital in north China and evaluate the treatment outcomes of antiseizure medications (ASMs). This study focuses on investigating the factors affecting the treatment outcomes, guiding the drug treatment, and judging the prognosis of elderly epilepsy patients.

Methods: We included patients aged 60 years or older at the time of their first seizure between January 2014 and August 2020. Demographic characteristics, effects of ASM, and the proportion of 1-year and long-term seizure freedom were reported. The univariate analysis and binary logistic regression were used to identify factors potentially influencing treatment outcomes.

Results: A total of 326 patients (median age 65 years, 67.2% men) were included. Moreover, 185 (56.7%) patients who received the first ASM monotherapy achieved 1 year of seizure freedom in the early stage. Compared with structural etiology, unknown etiology was associated with a higher likelihood of early seizure freedom (odds ratio [] = 0.545; < 0.05). Conversely, comorbid intracranial malignant tumors, taking carbamazepine (CBZ), and sodium valproate (VPA) were associated with a lower likelihood of seizure freedom ( = 3.527 vs. 6.550 vs. 8.829; < 0.05). At long-term follow-up, 263 (80.6%) patients achieved seizure freedom, with 79.8% on monotherapy.

Conclusions: Elderly patients with new-onset epilepsy responded well to the initial ASMs treatment. Patients with intracranial malignant tumors and prescribed VPA and CBZ were less likely to achieve early seizure freedom, while those with unknown etiology had higher probabilities of achieving early seizure freedom than those with structural etiology.

References

Hiyoshi T, Yagi K . Epilepsy in the elderly. Epilepsia. 2001; 41 Suppl 9:31-5. DOI: 10.1111/j.1528-1157.2000.tb02217.x. View

Roy P, Hernandez Ronquillo L, Ladino L, Tellez-Zenteno J . Risk factors associated with drug resistant focal epilepsy in adults: A case control study. Seizure. 2019; 73:46-50. DOI: 10.1016/j.seizure.2019.10.020. View

Gidey K, Chelkeba L, Gemechu T, Bekele Daba F . Treatment response and predictors in patients with newly diagnosed epilepsy in Ethiopia: a retrospective cohort study. Sci Rep. 2019; 9(1):16254. PMC: 6838070. DOI: 10.1038/s41598-019-52574-y. View

Johnson E, Krauss G, Lee A, Schneider A, Dearborn J, Kucharska-Newton A . Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study. JAMA Neurol. 2018; 75(11):1375-1382. PMC: 6248112. DOI: 10.1001/jamaneurol.2018.1935. View

Xia L, Ou S, Pan S . Initial Response to Antiepileptic Drugs in Patients with Newly Diagnosed Epilepsy As a Predictor of Long-term Outcome. Front Neurol. 2017; 8:658. PMC: 5727350. DOI: 10.3389/fneur.2017.00658. View

Wu A, Weingart J, Gallia G, Lim M, Brem H, Bettegowda C . Risk Factors for Preoperative Seizures and Loss of Seizure Control in Patients Undergoing Surgery for Metastatic Brain Tumors. World Neurosurg. 2017; 104:120-128. DOI: 10.1016/j.wneu.2017.05.028. View

Scheffer I, Berkovic S, Capovilla G, Connolly M, French J, Guilhoto L . ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58(4):512-521. PMC: 5386840. DOI: 10.1111/epi.13709. View

de Groot M, Reijneveld J, Aronica E, Heimans J . Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment. Brain. 2011; 135(Pt 4):1002-16. DOI: 10.1093/brain/awr310. View

Lance E, Sreenivasan A, Zabel T, Kossoff E, Comi A . Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes. J Child Neurol. 2012; 28(2):213-8. PMC: 4373084. DOI: 10.1177/0883073812463607. View

10.

Hartings J, Ross Bullock M, Okonkwo D, Murray L, Murray G, Fabricius M . Spreading depolarisations and outcome after traumatic brain injury: a prospective observational study. Lancet Neurol. 2011; 10(12):1058-64. DOI: 10.1016/S1474-4422(11)70243-5. View

11.

Koekkoek J, Kerkhof M, Dirven L, Heimans J, Reijneveld J, Taphoorn M . Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review. Neuro Oncol. 2015; 17(7):924-34. PMC: 5654353. DOI: 10.1093/neuonc/nov032. View

12.

Gibson L, Hanby M, Al-Bachari S, Parkes L, Allan S, Emsley H . Late-onset epilepsy and occult cerebrovascular disease. J Cereb Blood Flow Metab. 2014; 34(4):564-70. PMC: 3982095. DOI: 10.1038/jcbfm.2014.25. View

13.

Chen J, Zhou X, Lu Q, Jin L, Huang Y . New-Onset Geriatric Epilepsy in China: A Single-Center Study. Chin Med J (Engl). 2018; 131(24):2915-2920. PMC: 6302641. DOI: 10.4103/0366-6999.247194. View

14.

de Oliveira C, Grigoletto J, Canzian J, Duarte M, Duarte T, Furian A . Effect of atorvastatin on behavioral alterations and neuroinflammation during epileptogenesis. Epilepsy Behav. 2017; 78:109-117. DOI: 10.1016/j.yebeh.2017.10.021. View

15.

Sarkis R, Willment K, Pennell P, Marshall G . Late-onset unexplained epilepsy: What are we missing?. Epilepsy Behav. 2019; 99:106478. DOI: 10.1016/j.yebeh.2019.106478. View

16.

Redjal N, Reinshagen C, Le A, Walcott B, McDonnell E, Dietrich J . Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide. J Neurooncol. 2016; 127(3):505-14. DOI: 10.1007/s11060-016-2054-8. View

17.

Hitiris N, Mohanraj R, Norrie J, Sills G, Brodie M . Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007; 75(2-3):192-6. DOI: 10.1016/j.eplepsyres.2007.06.003. View

18.

Lattanzi S, Trinka E, Del Giovane C, Nardone R, Silvestrini M, Brigo F . Antiepileptic drug monotherapy for epilepsy in the elderly: A systematic review and network meta-analysis. Epilepsia. 2019; 60(11):2245-2254. DOI: 10.1111/epi.16366. View

19.

Werhahn K, Trinka E, Dobesberger J, Unterberger I, Baum P, Deckert-Schmitz M . A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. Epilepsia. 2015; 56(3):450-9. DOI: 10.1111/epi.12926. View

20.

Stephen L, Kelly K, Mohanraj R, Brodie M . Pharmacological outcomes in older people with newly diagnosed epilepsy. Epilepsy Behav. 2006; 8(2):434-7. DOI: 10.1016/j.yebeh.2005.11.007. View